Co-administration of omega-3 fatty acids and metformin showed more desirable effects than the single therapy on indices of bone mineralisation but not gluco-regulatory and antioxidant markers in diabetic rats
Although metformin (Met) is the most recommended anti-diabetogenic drug in type 2 diabetic state, the drug is known to compromise bone integrity. Like metformin, omega-3 fatty acids (ω-3) have gluco-regulatory action; however, it aids bone health. Therefore, the present study investigated the effect...
Main Authors: | Wale Johnson Adeyemi, Luqman Aribidesi Olayaki, Tahir Ahmad Abdussalam, Tolulope Olaoluwa Fabiyi, Temidayo Luqman Raji, Adenike Amatur-Rahman Adetunji |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219352539 |
Similar Items
-
Diclofenac – induced hepatotoxicity: Low dose of omega-3 fatty acids have more protective effects
by: Wale Johnson Adeyemi, et al.
Published: (2018-01-01) -
Additive and nonadditive effects of salmon calcitonin and omega-3 fatty acids on antioxidant, hematological and bone and cartilage markers in experimental diabetic-osteoarthritic rats
by: Wale J Adeyemi, et al.
Published: (2019-01-01) -
Omega 3 fatty acids favour lipid and bone metabolism in orchidectomised rats
by: Wale Johnson Adeyemi, et al.
Published: (2021-02-01) -
Recurrent hypoglycemia secondary to metformin toxicity in the absence of co-ingestions: a case report
by: Sarah Aldobeaban, et al.
Published: (2018-08-01) -
Role of oxidative stress in Cannabis sativa-associated spermatotoxicity: Evidence for ameliorative effect of combined but not separate melatonin and vitamin C
by: Isiaka Abdullateef Alagbonsi, et al.
Published: (2017-06-01)